vs
Digimarc CORP（DMRC）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
Spero Therapeutics, Inc.的季度营收约是Digimarc CORP的1.4倍（$12.6M vs $8.9M），Spero Therapeutics, Inc.净利率更高（250.7% vs -47.2%，领先297.9%），Spero Therapeutics, Inc.同比增速更快（24080.8% vs 2.9%），过去两年Spero Therapeutics, Inc.的营收复合增速更高（847.7% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
DMRC vs SPRO — 直观对比
营收规模更大
SPRO
是对方的1.4倍
$8.9M
营收增速更快
SPRO
高出24077.9%
2.9%
净利率更高
SPRO
高出297.9%
-47.2%
两年增速更快
SPRO
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $12.6M |
| 净利润 | $-4.2M | $31.5M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | — |
| 净利率 | -47.2% | 250.7% |
| 营收同比 | 2.9% | 24080.8% |
| 净利润同比 | 51.4% | 250.9% |
| 每股收益（稀释后） | $-0.18 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCSPRO
| Q4 25 | $8.9M | $12.6M | ||
| Q3 25 | $7.6M | $0 | ||
| Q2 25 | $8.0M | $0 | ||
| Q1 25 | $9.4M | $12.0K | ||
| Q4 24 | $8.7M | $52.0K | ||
| Q3 24 | $9.4M | $65.0K | ||
| Q2 24 | $10.4M | $114.0K | ||
| Q1 24 | $9.9M | $140.0K |
净利润DMRCSPRO
| Q4 25 | $-4.2M | $31.5M | ||
| Q3 25 | $-8.2M | $-7.4M | ||
| Q2 25 | $-8.2M | $-1.7M | ||
| Q1 25 | $-11.7M | $-13.9M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | $-17.1M | ||
| Q2 24 | $-9.3M | $-17.9M | ||
| Q1 24 | $-10.3M | $-12.7M |
毛利率DMRCSPRO
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCSPRO
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | — | ||
| Q2 25 | -105.2% | — | ||
| Q1 25 | -128.9% | -122758.3% | ||
| Q4 24 | -105.1% | — | ||
| Q3 24 | -120.4% | -28604.6% | ||
| Q2 24 | -96.2% | -16720.2% | ||
| Q1 24 | -109.2% | -9987.1% |
净利率DMRCSPRO
| Q4 25 | -47.2% | 250.7% | ||
| Q3 25 | -106.9% | — | ||
| Q2 25 | -102.6% | — | ||
| Q1 25 | -125.2% | -115550.0% | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | -26380.0% | ||
| Q2 24 | -89.3% | -15668.4% | ||
| Q1 24 | -104.0% | -9049.3% |
每股收益（稀释后）DMRCSPRO
| Q4 25 | $-0.18 | $0.56 | ||
| Q3 25 | $-0.38 | $-0.13 | ||
| Q2 25 | $-0.38 | $-0.03 | ||
| Q1 25 | $-0.55 | $-0.25 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.50 | $-0.32 | ||
| Q2 24 | $-0.43 | $-0.33 | ||
| Q1 24 | $-0.50 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $59.0M |
| 总资产 | $53.0M | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCSPRO
| Q4 25 | $12.9M | $40.3M | ||
| Q3 25 | $12.6M | $48.6M | ||
| Q2 25 | $16.1M | $31.2M | ||
| Q1 25 | $21.6M | $48.9M | ||
| Q4 24 | $28.7M | $52.9M | ||
| Q3 24 | $33.7M | $76.3M | ||
| Q2 24 | $41.5M | $63.5M | ||
| Q1 24 | $48.9M | $82.3M |
股东权益DMRCSPRO
| Q4 25 | $40.2M | $59.0M | ||
| Q3 25 | $41.4M | $26.5M | ||
| Q2 25 | $46.5M | $32.8M | ||
| Q1 25 | $50.0M | $33.8M | ||
| Q4 24 | $61.4M | $46.1M | ||
| Q3 24 | $70.2M | $65.5M | ||
| Q2 24 | $77.2M | $80.5M | ||
| Q1 24 | $84.5M | $96.2M |
总资产DMRCSPRO
| Q4 25 | $53.0M | $68.9M | ||
| Q3 25 | $55.4M | $54.2M | ||
| Q2 25 | $60.7M | $62.1M | ||
| Q1 25 | $66.5M | $77.7M | ||
| Q4 24 | $75.8M | $110.5M | ||
| Q3 24 | $85.0M | $135.2M | ||
| Q2 24 | $93.4M | $149.9M | ||
| Q1 24 | $99.7M | $167.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCSPRO
| Q4 25 | $991.0K | $-8.4M | ||
| Q3 25 | $-2.6M | $17.4M | ||
| Q2 25 | $-4.7M | $-17.7M | ||
| Q1 25 | $-5.5M | $-4.0M | ||
| Q4 24 | $-4.2M | $-23.4M | ||
| Q3 24 | $-7.1M | $12.8M | ||
| Q2 24 | $-6.8M | $-18.7M | ||
| Q1 24 | $-8.4M | $5.9M |
自由现金流DMRCSPRO
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCSPRO
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCSPRO
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.1% | — |
现金转化率DMRCSPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
SPRO
暂无分部数据
